Annual Accounts Payable
$2.22 M
+$1.60 M+258.78%
31 December 2023
Summary:
Qualigen Therapeutics annual accounts payable is currently $2.22 million, with the most recent change of +$1.60 million (+258.78%) on 31 December 2023. During the last 3 years, it has risen by +$1.34 million (+150.85%). QLGN annual accounts payable is now at all-time high.QLGN Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$1.64 M
-$215.50 K-11.62%
30 September 2024
Summary:
Qualigen Therapeutics quarterly accounts payable is currently $1.64 million, with the most recent change of -$215.50 thousand (-11.62%) on 30 September 2024. Over the past year, it has dropped by -$584.60 thousand (-26.30%). QLGN quarterly accounts payable is now -26.30% below its all-time high of $2.22 million, reached on 31 December 2023.QLGN Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
QLGN Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -26.3% |
| 3 y3 years | +150.8% | +84.9% |
| 5 y5 years | - | - |
QLGN Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +258.8% | -26.3% | +174.9% |
| 5 y | 5 years | at high | +343.9% | -26.3% | +301.3% |
| alltime | all time | at high | +343.9% | -26.3% | +301.3% |
Qualigen Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.64 M(-11.6%) |
| June 2024 | - | $1.85 M(+2.9%) |
| Mar 2024 | - | $1.80 M(-19.0%) |
| Dec 2023 | $2.22 M(+258.8%) | $2.22 M(+41.4%) |
| Sept 2023 | - | $1.57 M(-10.5%) |
| June 2023 | - | $1.76 M(+95.2%) |
| Mar 2023 | - | $899.90 K(+45.2%) |
| Dec 2022 | $619.60 K | $619.60 K(+4.0%) |
| Sept 2022 | - | $596.00 K(-35.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $918.30 K(-7.9%) |
| Mar 2022 | - | $997.40 K(+12.5%) |
| Dec 2021 | $886.20 K(+77.0%) | $886.20 K(-2.5%) |
| Sept 2021 | - | $908.70 K(+15.8%) |
| June 2021 | - | $784.50 K(+61.6%) |
| Mar 2021 | - | $485.60 K(+18.9%) |
| Dec 2020 | $500.80 K(-43.0%) | - |
| Sept 2020 | - | $408.30 K(-54.2%) |
| June 2020 | - | $892.20 K |
| Mar 2020 | $879.30 K | - |
FAQ
- What is Qualigen Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Qualigen Therapeutics?
- What is Qualigen Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Qualigen Therapeutics?
- What is Qualigen Therapeutics quarterly accounts payable year-on-year change?
What is Qualigen Therapeutics annual accounts payable?
The current annual accounts payable of QLGN is $2.22 M
What is the all time high annual accounts payable for Qualigen Therapeutics?
Qualigen Therapeutics all-time high annual accounts payable is $2.22 M
What is Qualigen Therapeutics quarterly accounts payable?
The current quarterly accounts payable of QLGN is $1.64 M
What is the all time high quarterly accounts payable for Qualigen Therapeutics?
Qualigen Therapeutics all-time high quarterly accounts payable is $2.22 M
What is Qualigen Therapeutics quarterly accounts payable year-on-year change?
Over the past year, QLGN quarterly accounts payable has changed by -$584.60 K (-26.30%)